Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 27% ± 12% | |
lung | 8 studies | 23% ± 10% | |
brain | 7 studies | 26% ± 9% | |
intestine | 5 studies | 21% ± 4% | |
bone marrow | 3 studies | 27% ± 12% | |
eye | 3 studies | 21% ± 4% | |
liver | 3 studies | 25% ± 5% | |
lymph node | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 12572.82 | 459 / 459 | 100% | 81.86 | 1118 / 1118 |
esophagus | 100% | 11512.99 | 1445 / 1445 | 100% | 80.47 | 183 / 183 |
intestine | 100% | 12529.32 | 966 / 966 | 100% | 83.88 | 527 / 527 |
lung | 100% | 12883.65 | 578 / 578 | 100% | 79.00 | 1155 / 1155 |
ovary | 100% | 11984.46 | 180 / 180 | 100% | 92.90 | 430 / 430 |
pancreas | 100% | 6236.19 | 328 / 328 | 100% | 64.11 | 178 / 178 |
prostate | 100% | 10779.61 | 245 / 245 | 100% | 72.44 | 502 / 502 |
skin | 100% | 14946.06 | 1809 / 1809 | 100% | 73.97 | 472 / 472 |
stomach | 100% | 9438.97 | 359 / 359 | 100% | 82.93 | 286 / 286 |
uterus | 100% | 13219.37 | 170 / 170 | 100% | 88.58 | 459 / 459 |
thymus | 100% | 13575.15 | 653 / 653 | 100% | 70.80 | 604 / 605 |
bladder | 100% | 10885.90 | 21 / 21 | 100% | 80.16 | 503 / 504 |
liver | 100% | 6610.81 | 226 / 226 | 100% | 39.27 | 405 / 406 |
kidney | 100% | 9474.80 | 89 / 89 | 100% | 49.81 | 897 / 901 |
brain | 100% | 7922.54 | 2630 / 2642 | 100% | 65.95 | 705 / 705 |
adrenal gland | 100% | 11851.09 | 258 / 258 | 98% | 41.73 | 226 / 230 |
adipose | 100% | 11837.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 85.67 | 29 / 29 |
spleen | 100% | 14393.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 85.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.22 | 1 / 1 |
blood vessel | 100% | 11120.51 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 8250.01 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 13504.78 | 921 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 47.20 | 79 / 80 |
heart | 98% | 7202.27 | 847 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006396 | Biological process | RNA processing |
GO_0035770 | Cellular component | ribonucleoprotein granule |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0000785 | Cellular component | chromatin |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0097157 | Molecular function | pre-mRNA intronic binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HNRNPL |
Protein name | HNRNPL protein Heterogeneous nuclear ribonucleoprotein L Heterogeneous nuclear ribonucleoprotein L (hnRNP L) |
Synonyms | HNRPL P/OKcl.14 |
Description | FUNCTION: Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements . Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts . Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter . As part of a ribonucleoprotein complex composed at least of ZNF827, HNRNPK and the circular RNA circZNF827 that nucleates the complex on chromatin, may negatively regulate the transcription of genes involved in neuronal differentiation . Regulates alternative splicing of a core group of genes involved in neuronal differentiation, likely by mediating H3K36me3-coupled transcription elongation and co-transcriptional RNA processing via interaction with CHD8. . |
Accessions | B4DVF8 ENST00000601813.1 M0R1W6 ENST00000600873.5 [P14866-2] ENST00000388749.7 P14866 ENST00000601449.5 ENST00000647557.2 Q6NTA2 A0A9L9PXI4 ENST00000598985.5 A0A3B3ITJ4 ENST00000600233.5 ENST00000634237.1 [P14866-2] M0QYL7 ENST00000221419.10 [P14866-1] M0QXS5 ENST00000634753.1 [P14866-1] |